Results

eNauka >  Rezultati >  Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy
Naziv: Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy
Autori: Tafrali, Christina; Paizi, Arsinoi; Borg, Joseph; Radmilović Milena  ; Bartsakoulia, Marina; Giannopoulou, Emily; Giannakopoulou, Olga; Stojiljković, Maja  ; Zukić, Branka  ; Poulas, Konstantinos;
Stavrou, Eleana F; Lambropoulou, Polyxeni; Kourakli, Alexandra; Felice, Alexander E; Papachatzopoulou, Adamantia; Philipsen, Sjaak; Pavlović, Sonja  ; Georgitsi, Marianthi; Patrinos, George P;
Godina: 2013
Publikacija: Pharmacogenomics
ISSN: 1462-2416 Pharmacogenomics Pretraži identifikator
Izdavač: Future Medicine Ltd, London
Tip rezultata: Naučni članak
Kolacija: vol. 14 br. 5 str. 469-483
DOI: 10.2217/pgs.13.31
WoS-ID: 000317177700012
Scopus-ID: 2-s2.0-84875936756
PMID: 23556445
URI: https://imagine.imgge.bg.ac.rs/handle/123456789/640
https://enauka.gov.rs/handle/123456789/284966
Projekat: long-term EMBO fellowship [ALTF 71-2011]
Research Promotion Foundation of Cyprus grant [RPFPiLambdaE046_02]
European Commission grant [FP7-200754]
'SEE-DRUG' project [FP7-REGPOT-2011-1]
Izvor metapodataka: Migracija
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

28
SCOPUSTM
10
PubMed CentralTM
21
OpenCitations
27
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.